AVRICORE HEALTH INC (AVCR.CA) Stock Price & Overview

TSX-V:AVCR • CA0545211090

Current stock price

0.065 CAD
0 (0%)
Last:

The current stock price of AVCR.CA is 0.065 CAD. Today AVCR.CA is down by 0%. In the past month the price decreased by -7.14%. In the past year, price increased by 18.18%.

AVCR.CA Key Statistics

52-Week Range0.045 - 0.1
Current AVCR.CA stock price positioned within its 52-week range.
1-Month Range0.065 - 0.075
Current AVCR.CA stock price positioned within its 1-month range.
Market Cap
6.584M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.02
Dividend Yield
N/A

AVCR.CA Stock Performance

Today
0%
1 Week
N/A
1 Month
-7.14%
3 Months
+30.00%
Longer-term
6 Months -13.33%
1 Year +18.18%
2 Years -58.06%
3 Years -77.59%
5 Years -71.74%
10 Years N/A

AVCR.CA Stock Chart

AVRICORE HEALTH INC / AVCR Daily stock chart

AVCR.CA Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to AVCR.CA. When comparing the yearly performance of all stocks, AVCR.CA turns out to be only a medium performer in the overall market: it outperformed 69.31% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AVCR.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to AVCR.CA. No worries on liquidiy or solvency for AVCR.CA as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AVCR.CA Earnings

Next Earnings DateApr 29, 2026
Last Earnings DateDec 1, 2025
PeriodQ3 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

AVCR.CA Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

AVCR.CA Groups

Sector & Classification

Index Membership

AVCR.CA Financial Highlights

Over the last trailing twelve months AVCR.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS decreased by -1820% compared to the year before.


Income Statements
Revenue(TTM)1.92M
Net Income(TTM)-1.63M
Industry RankSector Rank
PM (TTM) N/A
ROA -122.49%
ROE -125.89%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-105.56%
Sales Q2Q%-96.85%
EPS 1Y (TTM)-1820%
Revenue 1Y (TTM)-59.28%

AVCR.CA Ownership

Ownership
Inst OwnersN/A
Shares101.29M
Float91.58M
Ins Owners7.94%
Short Float %N/A
Short RatioN/A

About AVCR.CA

Company Profile

AVCR logo image Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is involved in the business of health data and point-of-care technologies. HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The firm offers tests for approximately 27 biomarkers with a focus on screening and managing chronic conditions, such as diabetes, heart disease and chronic kidney disease, as well as checking for common viral and bacterial infections. Its test menu includes total cholesterol, triglycerides, FRS, HbA1c, glucose, sodium, potassium, calcium, chloride, total CO2, COVID-19, Flu A, Flu B, and Strep A.

Company Info

IPO: 2001-07-31

AVRICORE HEALTH INC

1120 - 789 West Pender Street

Vancouver BRITISH COLUMBIA V7X 1H7 CA

CEO: Hector Bremner

Employees: 0

AVCR Company Website

AVCR Investor Relations

Phone: 16047738943

AVRICORE HEALTH INC / AVCR.CA FAQ

What does AVCR do?

Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is involved in the business of health data and point-of-care technologies. HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The firm offers tests for approximately 27 biomarkers with a focus on screening and managing chronic conditions, such as diabetes, heart disease and chronic kidney disease, as well as checking for common viral and bacterial infections. Its test menu includes total cholesterol, triglycerides, FRS, HbA1c, glucose, sodium, potassium, calcium, chloride, total CO2, COVID-19, Flu A, Flu B, and Strep A.


Can you provide the latest stock price for AVRICORE HEALTH INC?

The current stock price of AVCR.CA is 0.065 CAD.


Does AVCR stock pay dividends?

AVCR.CA does not pay a dividend.


How is the ChartMill rating for AVRICORE HEALTH INC?

AVCR.CA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Should I buy AVCR stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AVCR.CA.


When does AVRICORE HEALTH INC (AVCR.CA) report earnings?

AVRICORE HEALTH INC (AVCR.CA) will report earnings on 2026-04-29.